DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma

NCT02487017 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shenzhen Hornetcorn Bio-technology Company, LTD

Collaborators